Hospital
Prime Healthcare Services Encino LLC
Prime Healthcare Services Encino LLC was paid $1.52M by Medicaid between Jan 2018 and Dec 2024, across 78 billing codes. Its largest line is 0450, Emergency room services — 33% of everything it billed.
33Billing provider infoPRIME HEALTHCARE SERVICES ENCINO LLC
ENCINO, CA 91436
ENCINO, CA 91436
33aNPI1437322377assigned 04/11/2008
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.52M
24GClaims99,588
24DCodes billed78
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#262 of 410
Median peer was paid$6.90M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,422 | $231K | |
| 2019 | 16,258 | $289K | |
| 2020 | 12,083 | $156K | |
| 2021 | 11,107 | $187K | |
| 2022 | 13,917 | $233K | |
| 2023 | 15,580 | $228K | |
| 2024incomplete | 13,221 | $197K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 33% | 15,602 | 13,534 | $496K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 6.6% | 2,393 | 1,648 | $100K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.5% | 1,029 | 989 | $83K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.1% | 2,131 | 1,923 | $78K |
| 0270 | 4.4% | 7,210 | 4,436 | $67K | |
| 0272 | 3.8% | 6,266 | 5,668 | $58K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.6% | 3,625 | 3,306 | $55K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.2% | 616 | 595 | $48K |
| J3490 | Unclassified drugs | 2.7% | 4,809 | 3,663 | $41K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.6% | 2,626 | 2,149 | $40K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.3% | 1,661 | 1,497 | $34K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.3% | 5,746 | 5,298 | $34K |
66 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.3% | 1,451 | $34K |
| 71045 | Radiologic examination, chest; single view | 2.1% | 3,515 | $31K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 6,566 | $31K |
| 80076 | 1.9% | 4,667 | $28K | |
| 99285 | Emergency room visit (most serious) | 1.8% | 121 | $27K |
| 99199 | Unlisted special service, procedure or report | 1.6% | 534 | $25K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.3% | 1,290 | $19K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 552 | $18K |
| 0250 | 1.2% | 2,497 | $18K | |
| 84484 | <1% | 2,616 | $15K | |
| 0258 | <1% | 573 | $11K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 261 | $11K |
| 99284 | Emergency room visit (serious) | <1% | 210 | $10K |
| 83880 | <1% | 608 | $9K | |
| 83690 | <1% | 1,958 | $9K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 252 | $8K |
| 81001 | <1% | 2,960 | $7K | |
| 84703 | <1% | 1,352 | $7K | |
| A9150 | Non-prescription drugs | <1% | 854 | $6K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,284 | $5K |
| Z7502 | <1% | 140 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 987 | $4K |
| 85730 | <1% | 1,194 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,008 | $4K |
| 80053 | Comprehensive metabolic panel | <1% | 506 | $3K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 778 | $3K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 41 | $3K |
| Z7610 | <1% | 157 | $3K | |
| 87040 | <1% | 401 | $2K | |
| 99406 | <1% | 328 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 34 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 382 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 141 | $2K |
| 80299 | <1% | 197 | $2K | |
| 83605 | <1% | 319 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 38 | $2K |
| 83735 | <1% | 288 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 322 | $1K |
| 85379 | <1% | 213 | $1K | |
| 84702 | <1% | 250 | $1K | |
| 99283 | Emergency room visit (moderate) | <1% | 41 | $800.92 |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,081 | $780.80 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 113 | $723.36 |
| 81003 | <1% | 498 | $621.94 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 116 | $600.52 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 123 | $581.45 |
| 87400 | <1% | 197 | $546.43 | |
| 87070 | <1% | 33 | $517.66 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 45 | $504.65 |
| 80320 | <1% | 80 | $402.50 | |
| 0320 | <1% | 24 | $365.28 | |
| 81000 | <1% | 183 | $290.38 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 58 | $244.40 |
| J3590 | Unclassified biologics | <1% | 42 | $230.83 |
| A4649 | Surgical supply; miscellaneous | <1% | 870 | $179.35 |
| 86403 | <1% | 33 | $172.45 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 27 | $169.91 |
| 73630 | <1% | 13 | $157.33 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 12 | $103.23 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 14 | $80.31 |
| 0636 | <1% | 27 | $61.78 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 15 | $53.77 |
| 82550 | <1% | 12 | $45.62 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 15 | $41.33 |
| 82962 | <1% | 16 | $9.93 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 0% | 341 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHELL, TROY (SECRETARY & GENERAL COUNSEL)
| Provider | Location | Paid |
|---|---|---|
| Prime Healthcare Services - ST. Mary's Passaic LLC | Passaic, NJ | $56.16M |
| Prime Healthcare Anaheim, LLC | Anaheim, CA | $8.85M |
| Prime Healthcare Services - ST. Mary's Passaic, LLC | Passaic, NJ | $7.25M |
| Prime Healthcare Services - ST. Mary's Passaic, LLC | Passaic, NJ | $342K |
| Prime Healthcare Services - ST. Mary's Passaic, LLC | Passaic, NJ | $9K |
| Prime Healthcare Centinela LLC | Inglewood, CA | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.